CYTOF — Altamira Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Auris Medical Announces Acquisition Of Rna Therapeutics Company And Plans For Strategic Repositioning
Brief: Auris Medical Starts Preparations For Covid-19 Trial With Bentrio In India
Brief: Auris Medical Announces Completion Of Bentrio Conformity Assessment Procedure For Marketing In EU
Brief: Auris Medical Reaches Midpoint For Enrollment In Part B Of AM-125 Phase 2 Travers Trial In Acute Peripheral Vertigo
Brief: Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301
Brief: Auris Medical Says Launch Of Am-301 Expected In Selected Markets Towards End Of Q2 2021
Brief: Auris Medical Announces Initiation Of Clinical Investigation Of Am-301 In Allergic Rhinitis
Auris Medical: Rises as co starts clinical trial of nasal spray to treat allergic rhinitis
Brief: Auris Medical Expects To Meet Requirements For CE Marking For AM-301 In Q2 Of 2021
U.S. STOCKS ON THE MOVE-Chevron, BlackBerry, ReneSola
Auris Medical Holding: Down on discounted stock offering
U.S. STOCKS ON THE MOVE-Norwegian Cruise Line, Lyft, Palantir, Sempra Energy
U.S. STOCKS ON THE MOVE-Trip.com, ZommInfo, Moderna
Brief: Auris Medical Holding Prices $8,000,000 Common Shares Offering Priced At-The-Market
U.S. STOCKS ON THE MOVE-Pfizer, BioNTech, Disney
U.S. STOCKS ON THE MOVE-J&J, Mogo, BridgeBio Pharma, Sandridge Energy
Auris Medical: Surges as nasal spray to prevent COVID-19 shows promise
U.S. STOCKS ON THE MOVE-CSX Corp, Square, Delta Air, Suncor, BlackBerry
Brief: Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection